These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 15833880)

  • 1. IFN unresponsiveness in LNCaP cells due to the lack of JAK1 gene expression.
    Dunn GP; Sheehan KC; Old LJ; Schreiber RD
    Cancer Res; 2005 Apr; 65(8):3447-53. PubMed ID: 15833880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential role of Janus family kinases (JAKs) in interferon-gamma-induced lung epithelial ICAM-1 expression: involving protein interactions between JAKs, phospholipase Cgamma, c-Src, and STAT1.
    Chang YJ; Holtzman MJ; Chen CC
    Mol Pharmacol; 2004 Mar; 65(3):589-98. PubMed ID: 14978237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IFI16 in human prostate cancer.
    Alimirah F; Chen J; Davis FJ; Choubey D
    Mol Cancer Res; 2007 Mar; 5(3):251-9. PubMed ID: 17339605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The TATA-containing core promoter of the type II collagen gene (COL2A1) is the target of interferon-gamma-mediated inhibition in human chondrocytes: requirement for Stat1 alpha, Jak1 and Jak2.
    Osaki M; Tan L; Choy BK; Yoshida Y; Cheah KS; Auron PE; Goldring MB
    Biochem J; 2003 Jan; 369(Pt 1):103-15. PubMed ID: 12223098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of interferon-gamma inducibility of TAP1 and LMP2 in a renal cell carcinoma cell line.
    Dovhey SE; Ghosh NS; Wright KL
    Cancer Res; 2000 Oct; 60(20):5789-96. PubMed ID: 11059775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complementation by the protein tyrosine kinase JAK2 of a mutant cell line defective in the interferon-gamma signal transduction pathway.
    Watling D; Guschin D; Müller M; Silvennoinen O; Witthuhn BA; Quelle FW; Rogers NC; Schindler C; Stark GR; Ihle JN
    Nature; 1993 Nov; 366(6451):166-70. PubMed ID: 7901766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein tyrosine kinase Pyk2 mediates the Jak-dependent activation of MAPK and Stat1 in IFN-gamma, but not IFN-alpha, signaling.
    Takaoka A; Tanaka N; Mitani Y; Miyazaki T; Fujii H; Sato M; Kovarik P; Decker T; Schlessinger J; Taniguchi T
    EMBO J; 1999 May; 18(9):2480-8. PubMed ID: 10228162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokine-stimulated GTP cyclohydrolase I expression in endothelial cells requires coordinated activation of nuclear factor-kappaB and Stat1/Stat3.
    Huang A; Zhang YY; Chen K; Hatakeyama K; Keaney JF
    Circ Res; 2005 Feb; 96(2):164-71. PubMed ID: 15604419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon-induced nuclear signalling by Jak protein tyrosine kinases.
    Silvennoinen O; Ihle JN; Schlessinger J; Levy DE
    Nature; 1993 Dec; 366(6455):583-5. PubMed ID: 7504785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinase-negative mutants of JAK1 can sustain interferon-gamma-inducible gene expression but not an antiviral state.
    Briscoe J; Rogers NC; Witthuhn BA; Watling D; Harpur AG; Wilks AF; Stark GR; Ihle JN; Kerr IM
    EMBO J; 1996 Feb; 15(4):799-809. PubMed ID: 8631301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IFN-gamma priming up-regulates IFN-stimulated gene factor 3 (ISGF3) components, augmenting responsiveness of IFN-resistant melanoma cells to type I IFNs.
    Wong LH; Hatzinisiriou I; Devenish RJ; Ralph SJ
    J Immunol; 1998 Jun; 160(11):5475-84. PubMed ID: 9605150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycobacterium avium infection of mouse macrophages inhibits IFN-gamma Janus kinase-STAT signaling and gene induction by down-regulation of the IFN-gamma receptor.
    Hussain S; Zwilling BS; Lafuse WP
    J Immunol; 1999 Aug; 163(4):2041-8. PubMed ID: 10438942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A selective defect of IFN-gamma- but not of IFN-alpha-induced JAK/STAT pathway in a subset of U937 clones prevents the antiretroviral effect of IFN-gamma against HIV-1.
    Bovolenta C; Lorini AL; Mantelli B; Camorali L; Novelli F; Biswas P; Poli G
    J Immunol; 1999 Jan; 162(1):323-30. PubMed ID: 9886402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of interferon-stimulated JAK-STAT signaling by a tick-borne flavivirus and identification of NS5 as an interferon antagonist.
    Best SM; Morris KL; Shannon JG; Robertson SJ; Mitzel DN; Park GS; Boer E; Wolfinbarger JB; Bloom ME
    J Virol; 2005 Oct; 79(20):12828-39. PubMed ID: 16188985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polypeptide signalling to the nucleus through tyrosine phosphorylation of Jak and Stat proteins.
    Shuai K; Ziemiecki A; Wilks AF; Harpur AG; Sadowski HB; Gilman MZ; Darnell JE
    Nature; 1993 Dec; 366(6455):580-3. PubMed ID: 7504784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth hormone (GH) receptors in prostate cancer: gene expression in human tissues and cell lines and characterization, GH signaling and androgen receptor regulation in LNCaP cells.
    Weiss-Messer E; Merom O; Adi A; Karry R; Bidosee M; Ber R; Kaploun A; Stein A; Barkey RJ
    Mol Cell Endocrinol; 2004 May; 220(1-2):109-23. PubMed ID: 15196705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down-regulation of neu/HER-2 by interferon-gamma in prostate cancer cells.
    Kominsky SL; Hobeika AC; Lake FA; Torres BA; Johnson HM
    Cancer Res; 2000 Jul; 60(14):3904-8. PubMed ID: 10919667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined genetic and epigenetic interferences with interferon signaling expose prostate cancer cells to viral infection.
    Danziger O; Shai B; Sabo Y; Bacharach E; Ehrlich M
    Oncotarget; 2016 Aug; 7(32):52115-52134. PubMed ID: 27366948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human malignant mesothelioma cell growth: activation of janus kinase 2 and signal transducer and activator of transcription 1alpha for inhibition by interferon-gamma.
    Buard A; Vivo C; Monnet I; Boutin C; Pilatte Y; Jaurand MC
    Cancer Res; 1998 Feb; 58(4):840-7. PubMed ID: 9485044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolactin activates Stat1 but does not antagonize Stat1 activation and growth inhibition by type I interferons in human breast cancer cells.
    Schaber JD; Fang H; Xu J; Grimley PM; Rui H
    Cancer Res; 1998 May; 58(9):1914-9. PubMed ID: 9581833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.